Insights from 2023 WCLC

 

Videos
14:02

Insights from 2023 WCLC

WCLC 2023 Insights: "MSI and MMR-D Define a Distinct Subset of Lung Cancers Characterized by Smoking Exposure, High TMB, and MLH1 Inactivation"

FEATURING Soo-Ryum Yang
  • 106 views
  • November 17, 2023
  • 3
05:32

Insights from 2023 WCLC

Molecular and Clinical Characterization of NSCLC With MET Fusions

FEATURING Chul Kim
  • 149 views
  • October 22, 2023
  • 1
08:59

Insights from 2023 WCLC

WCLC 2023 Insights: "SWOG S1609 (DART) Phase 2 Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors - Bronchioloalveolar Carcinoma of the Lung"

FEATURING Young Chae
  • 58 views
  • October 22, 2023
  • 2
15:49

Insights from 2023 WCLC

WCLC 2023 Insights: "NSCLC Microenvironment Subtypes Correlate with Response and Survival to Immune Checkpoint Inhibitor Therapy"

FEATURING Dhruv Bansal
  • 87 views
  • October 22, 2023
  • 1
08:40

Insights from 2023 WCLC

WCLC 2023 Insights: "PD-L1 Subgroups in the Phase 3 LUNAR Study - TTFields and Immune Checkpoint Inhibitor in mNSCLC"

FEATURING Rupesh Kotecha
  • 46 views
  • October 17, 2023
  • 1
05:48

Insights from 2023 WCLC

WCLC 2023 Insights: "Association of TTF-1 Expression With Outcomes to IO & KRAS G12C Inhibition in Lung Adenocarcinoma"

FEATURING Alessandro Di Federico
  • 77 views
  • October 17, 2023
  • 1
08:54

Insights from 2023 WCLC

WCLC 2023 Insights: "AI as a First Read Filter in Lung Cancer Screening"

FEATURING Harriet Lancaster
  • 294 views
  • October 17, 2023
  • 4
07:13

Insights from 2023 WCLC

WCLC 2023 Insights: "5-Year Survival of Pembro + Chemo for mNSCLC With PD-L1 Tumor Proportion Score <1%"

FEATURING Shirish Gadgeel
  • 296 views
  • October 9, 2023
  • 1
09:08

Insights from 2023 WCLC

WCLC 2023 Insights: "Mechanisms of Resistance to KRAS G12C Inhibitors in NSCLC"

FEATURING Biagio Ricciuti
  • 84 views
  • October 9, 2023
  • 1
06:29

Insights from 2023 WCLC

WCLC 2023 Insights: "KRYSTAL-1 - Two-Year Follow-Up of Adagrasib Monotherapy in Patients With Advanced/Metastatic KRASG12Cm NSCLC"

FEATURING Shirish Gadgeel
  • 163 views
  • October 9, 2023
  • 2
09:57

Insights from 2023 WCLC

WCLC 2023 Insights: "3-Year Outcomes & Correlative Analyses in Patients With NSCLC and a Very High PD-L1 Tumor Proportion Score ≥ 90% Treated With 1L Cemiplimab & Pembro"

FEATURING Biagio Ricciuti
  • 82 views
  • October 9, 2023
  • 1
07:51

Insights from 2023 WCLC

WCLC 2023 Insights: "Phase 3 AEGEAN Study - Neoadjuvant Durvalumab + Chemo Followed by Adjuvant Durvalumab in Resectable EGFRm NSCLC"

FEATURING David Harpole
  • 86 views
  • October 9, 2023
  • 3
06:28

Insights from 2023 WCLC

WCLC 2023 Insights: "Results of the SQUINT Trial - Do MAPK1/MAPK3 Mutations Enhance IO Efficacy in Lung Squamous Cell Carcinoma?"

FEATURING Gabriele Minuti
  • 59 views
  • October 9, 2023
  • 2
11:40

Insights from 2023 WCLC

WCLC 2023 Insights: "Prognosis in Lung Adenocarcinoma With Upregulated Expression of IGF2BP2 - How Does It Affect Immune Microenvironment and Drug Sensitivity"

FEATURING Lele Zhang
  • 66 views
  • October 3, 2023
  • 2
09:12

Insights from 2023 WCLC

WCLC 2023 Insights: "ILLUMINATE - Efficacy & Safety of Durvalumab-Tremelimumab & Chemotherapy in EGFRm NSCLC Following Progression on EGFR Inhibitors"

FEATURING Chee Khoon Lee
  • 76 views
  • September 22, 2023
  • 1
16:43

Insights from 2023 WCLC

WCLC 2023 Insights: "Osimertinib in Resected EGFRm NSCLC - ADAURA Trial"

FEATURING Arianna Marinello
  • 66 views
  • September 22, 2023
  • 1
08:45

Insights from 2023 WCLC

WCLC 2023 Insights: "Long-Term Outcomes by Radiation Technique for Locally-Advanced NSCLC: A Secondary Analysis of NRG Oncology-RTOG 0617 at 5-Years"

FEATURING Stephen Chun
  • 89 views
  • September 22, 2023
  • 3